AAAAAA
Results:
1-7
|
Results: 7
Authors:
FALKSON CI
FALKSON HC
Citation: Ci. Falkson et Hc. Falkson, PROGNOSTIC FACTORS IN METASTATIC MALIGNANT-MELANOMA - AN ANALYSIS OF 236 PATIENTS TREATED ON CLINICAL RESEARCH STUDIES AT THE DEPARTMENT-OF-MEDICAL-ONCOLOGY, UNIVERSITY-OF-PRETORIA, SOUTH-AFRICA FROM 1972-1992, Oncology, 55(1), 1998, pp. 59-64
Authors:
TORMEY DC
GRAY R
FALKSON HC
Citation: Dc. Tormey et al., POSTCHEMOTHERAPY ADJUVANT TAMOXIFEN THERAPY BEYOND 5 YEARS IN PATIENTS WITH LYMPH NODE-POSITIVE BREAST-CANCER, Journal of the National Cancer Institute, 88(24), 1996, pp. 1828-1833
Authors:
FALKSON CI
FALKSON HC
Citation: Ci. Falkson et Hc. Falkson, A RANDOMIZED STUDY OF CGS 16949A (FADROZOLE) VERSUS TAMOXIFEN IN PREVIOUSLY UNTREATED POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 7(5), 1996, pp. 465-469
Authors:
FALKSON CI
FALKSON HC
FALKSON G
Citation: Ci. Falkson et al., CISPLATIN VERSUS CISPLATIN PLUS D-TRP-6-LHRH IN THE TREATMENT OF OVARIAN-CANCER - A PILOT TRIAL TO INVESTIGATE THE EFFECT OF THE ADDITION OF A GNRH ANALOG TO CISPLATIN, Oncology, 53(4), 1996, pp. 313-317
Authors:
FALKSON CI
FALKSON HC
Citation: Ci. Falkson et Hc. Falkson, ANTIEMETIC EFFICACY OF TROPISETRON IN PATIENTS FAILING PREVIOUS ANTIEMETIC THERAPY, Oncology, 52(5), 1995, pp. 427-431
Authors:
FALKSON CI
FALKSON G
FALKSON HC
Citation: Ci. Falkson et al., PHASE-II TRIAL OF FOTEMUSTINE IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA, Investigational new drugs, 12(3), 1994, pp. 251-254
Authors:
FALKSON CI
FALKSON G
FALKSON HC
UYS A
KERENROSENBERG S
Citation: Ci. Falkson et al., FIVB PLUS GM-CSF IN METASTATIC COLORECTAL-CANCER, Investigational new drugs, 12(1), 1994, pp. 49-52
Risultati:
1-7
|